Skip to main content
. 2021 Nov 18;10(22):5386. doi: 10.3390/jcm10225386

Table 3.

Parameters associated with in-hospital mortality (panel A) and 1-year mortality (panel B).

A
Parameter In-Hospital Mortality Univariate Analysis Multivariate Logistic
Regression Analysis
Survived
(n = 305)
Deceased
(n = 32)
Odds Ratio (95% C.I.) p-Value ^ Odds Ratio (95% C.I.) p-Value
Age 64 (50–73) 68 (55–75) 0.113
Gender:
Male 213 (69.84) 24 (75) 0.77 (0.33–1.78) 0.685
Female 92 (30.16) 8 (25)
IE etiology: 0.004 1.57 (1.16–2.13) 0.003
S. aureus 47 (15.4) 6 (18.75)
Coagulase-negative Staphylococci 55 (18.03) 8 (25)
Streptococci 95 (31.1) 2 (6.25)
Enterococci 48 (15.7) 4 (12.5)
Gram negatives 10 (3.2) 4 (12.5)
Other pathogens 6 (1.9) 3 (9.3)
Negative cultures 44 (14.4) 5 (15.7)
Infection type: (n = 218) (n = 20) 4.10 (1.51–11.10) 0.004 10.49 (2.79–39.48) 0.001
Native 139 (63.7) 6 (30)
Prosthetic 79 (36.3) 14 (70)
Charlson Comorbidity Index (n = 180)
5 (3–7)
(n = 18)
6 (4–7)
0.253
Embolic event *: 1.19 (0.55–2.57) 0.689
Yes 93 (30.5) 11 (34.4)
No 212 (69.5) 21 (65.6)
Intracardiac abscess 2.34 (0.98–5.58) 0.059
Yes 38 (12.4) 8 (25)
No 267 (87.6) 24 (75)
Surgery indication: (n = 303) (n = 32) 3.83 (1.13–12.90) 0.020 14.07 (2.68–73.80) 0.002
Yes 217 (71.6) 29 (90.6)
No 86 (28.4) 3 (9.4)
D-dimers, ng/mL 582 (274–1041) 869 (498–1927) 0.012 1.00 (1.00–1.00) 0.005
Fibrinogen, mg/dL 407 (324–535) 419 (299–527) 0.933
PT-INR 1.30 (1.15–1.70) 1.50 (1.22–2.6) 0.013 1.61 (0.94–2.74) 0.077
aPTT, seconds 32.3 (29.6–37.8) 36.6 (31.5–43) 0.090
Platelet count, cells 103/μL 204 (152–262) 201 (103–279) 0.398
Homocysteine, mcmol/L 15 (12–20) 15 (12–22) 0.886
B
Parameter 1-Year Mortality Univariate Analysis Multivariate Logistic
Regression Analysis
Survived
(n = 191)
Deceased
(n = 76)
Odds Ratio (95% C.I.) p-Value ^ Odds Ratio (95% C.I.) p-Value
Age 62 (49–73) 65 (55–75) 0.058
Gender: 0.81 (0.45–1.46) 0.558
Male 130 (68.1) 55 (72.3)
Female 61 (31.9) 21 (27.7)
IE etiology: 0.017 1.34 (0.92–1.96) 0.123
S. aureus 25 (13.1) 12 (15.8)
Coagulase-negative Staphylococci 34 (17.8) 18 (23.7)
Streptococci 69 (36.1) 12 (15.8)
Enterococci 34 (17.8) 11 (14.5)
Gram negatives 6 (3.1) 5 (6.6)
Other pathogens 3 (1.6) 3 (3.9)
Negative cultures 20 (10.5) 15 (19.7)
Infection type: (n = 141) (n = 51) 2.18 (1.13–4.17) 0.020 12.90 (3.02–55.09) 0.001
Native 93 (66) 24 (47)
Prosthetic 48 (34) 27 (53)
Charlson Comorbidity Index (n = 110)
5 (2–7)
(n = 36)
6 (4.2–7)
0.009 1.32 (1.00–1.74) 0.049
Embolic event *: 0.76 (0.42–1.37) 0.461
Yes 61 (32) 20 (26.3)
No 130 (68) 56 (73.7)
Intracardiac abscess 1.37 (0.66–1.84) 0.439
Yes 25 (15.5) 13 (17.1)
No 136 (84.5) 63 (82.9)
Surgery indication: 3.83 (1.13–12.90) 0.005 2.59 (4.515–235.17) 0.001
Yes 133 (70) 66 (86.8)
No 57 (30) 10 (13.2)
D-dimers, ng/mL 567 (315–1028) 667 (290–1326) 0.390
Fibrinogen, mg/dL 424 (331–567) 438 (322–546) 0.821
PT-INR 1.30 (1.15–1.60) 1.30 (1.20–2.28) 0.078
aPTT, seconds 32.3 (30.1–37.6) 36.6 (31.5–44) 0.021 1.09 (1.02–1.17) 0.012
Platelet count, cells 10 3/μL 209 (154–275) 201 (143–266) 0.275
Homocysteine, μmol/L 14.2 (11.4–19) 16 (12–22) 0.059

Data are presented as median with interquartile range (IQR) or as number and percentage (%). ^ The p-value was generated by Fisher’s exact test or Pearson chi-square test for categorical variables, and Mann–Whitney for numerical variables; * includes stroke. Abbreviations: aPTT: activated partial thromboplastin time; IE: infective endocarditis; PT-INR: prothrombin time international normalized ratio. Statistically significant values are marked in bold.